Press "Enter" to skip to content

New patent for Astrazeneca Ab drug FARXIGA


Annual Drug Patent Expirations for FARXIGA
Annual Drug Patent Expirations for FARXIGA

Farxiga is a drug marketed by Astrazeneca Ab
and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug.

This drug has two hundred and eigthy-six patent family members in forty-four countries.

The generic ingredient in FARXIGA is dapagliflozin propanediol. One supplier is listed for this compound. Additional details are available on the dapagliflozin propanediol profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

    Do NOT follow this link or you will be banned from the site!